Long-term Debt and Lease Obligation of RECURSION PHARMACEUTICALS, INC. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
RECURSION PHARMACEUTICALS, INC. quarterly Long-term Debt and Lease Obligation in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • RECURSION PHARMACEUTICALS, INC. Long-term Debt and Lease Obligation for the quarter ending 31 Dec 2025 was $9,564,000, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $9,564,000 -$9,458,000 -50% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $11,902,000 -$8,608,000 -42% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $14,196,000 -$8,725,000 -38% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $16,446,000 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $19,022,000 +$17,921,000 +1628% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $20,510,000 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $22,921,000 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q4 2023 $1,101,000 31 Dec 2023 10-K 28 Feb 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.